Cargando…
Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists
Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are infrequent autoimmune cholestatic liver diseases, that disproportionate to their incidence and prevalence, remain very important causes of morbidity and mortality for patients with liver disease. Mechanistic insights spanni...
Autores principales: | Trivedi, Palak J., Corpechot, Christophe, Pares, Albert, Hirschfield, Gideon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864755/ https://www.ncbi.nlm.nih.gov/pubmed/26290473 http://dx.doi.org/10.1002/hep.28128 |
Ejemplares similares
-
The Immunogenetics of Autoimmune Cholestasis
por: Trivedi, Palak J., et al.
Publicado: (2016) -
Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011) -
Paying clinicians to join clinical trials: a review of guidelines and interview study of trialists
por: Raftery, James, et al.
Publicado: (2009) -
Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges
por: Pugliese, Nicola, et al.
Publicado: (2022) -
Confessions of a chagrined trialist
por: Goodman, Steven
Publicado: (2011)